Compound Detail
CHEMBL1688243
INCB-9471 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
CCO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C
Basic Information
| ChEMBL ID | CHEMBL1688243 |
| Name | INCB-9471 |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | ZMCJFJZOSKEMOM-DNKZPPIMSA-N |
3
Targets
10
Activities
2
Assay Types
21
PK Parameters
17
Publications
4
Known Names
1
Indications
1
Mechanisms
Molecular Properties
559.7
MW (Da)
4.82
ALogP
6
HBA
0
HBD
61.8
PSA (Ų)
0.52
QED
1
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| C-C chemokine receptor type 5 antagonist | ANTAGONIST | C-C chemokine receptor type 5 | ✓ | ✓ |
Indications
HIV Infections
Activity Summary
IC50 9 meas. best 9.8
Kd 1 meas. best 8.51
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Human immunodeficiency virus 1 CHEMBL378 | IC50 | 9.8 | 9.62 | 0.2 | 2 |
| C-C chemokine receptor type 5 CHEMBL274 | IC50 | 8.82 | 8.3933 | 1.5 | 6 |
| C-C chemokine receptor type 5 CHEMBL274 | Kd | 8.51 | 8.51 | 3.1 | 1 |
| Voltage-gated inwardly rectifying potassium channel KCNH2 CHEMBL240 | IC50 | 5.35 | 5.35 | 4500.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 1621.95 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 4395.73 | ng.hr.mL-1 | Canis lupus familiaris |
| AUC | 30871.95 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 83828.87 | ng.hr.mL-1 | Canis lupus familiaris |
| CL | 10.33 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 3.333 | mL.min-1.kg-1 | Canis lupus familiaris |
| Cmax | 4071.0 | nM | Rattus norvegicus |
| Cmax | 14007.0 | nM | Canis lupus familiaris |
| F | 100.0 | % | Rattus norvegicus |
| F | 95.0 | % | Canis lupus familiaris |
| Fu | 0.16 | - | Homo sapiens |
| T1/2 | 6.0 | hr | Rattus norvegicus |
| T1/2 | 11.0 | hr | Canis lupus familiaris |
| T1/2 | 12.0 | hr | Rattus norvegicus |
| T1/2 | 17.0 | hr | Canis lupus familiaris |
| T1/2 | 58.0 | hr | Homo sapiens |
| T1/2 | 58.0 | hr | Homo sapiens |
| Tmax | 3.0 | hr | Rattus norvegicus |
| Tmax | 0.5 | hr | Canis lupus familiaris |
| Vd | 4.1 | L/hr | Rattus norvegicus |
| Vd | 3.8 | L/hr | Canis lupus familiaris |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 24900235 | 10.1021/ml1001536 | Human immunodeficiency virus 1 | 11 |
| 24900235 | 10.1021/ml1001536 | Rattus norvegicus | 10 |
| 24900235 | 10.1021/ml1001536 | Canis familiaris | 9 |
| 24900235 | 10.1021/ml1001536 | C-C chemokine receptor type 5 | 6 |
| 22931505 | 10.1021/jm300682j | No relevant target | 1 |
| 22931505 | 10.1021/jm300682j | C-C chemokine receptor type 5 | 1 |
| 22931505 | 10.1021/jm300682j | Homo sapiens | 1 |
| 24900235 | 10.1021/ml1001536 | Homo sapiens | 1 |
| 24900235 | 10.1021/ml1001536 | ADMET | 1 |
| 24900235 | 10.1021/ml1001536 | Caco-2 | 1 |
| 24900235 | 10.1021/ml1001536 | Cytochrome P450 2C19 | 1 |
| 24900235 | 10.1021/ml1001536 | Cytochrome P450 2C9 | 1 |
| 24900235 | 10.1021/ml1001536 | Cytochrome P450 1A2 | 1 |
| 24900235 | 10.1021/ml1001536 | Cytochrome P450 2D6 | 1 |
| 24900235 | 10.1021/ml1001536 | Cytochrome P450 3A4 | 1 |
| 24900235 | 10.1021/ml1001536 | Serum | 1 |
| 24900235 | 10.1021/ml1001536 | Voltage-gated inwardly rectifying potassium channel KCNH2 | 1 |
Data from ChEMBL 36 via Core Engine